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         The present study was carried out to examine possible gene expression 
changes that occur in the brainstem in a mouse facial carrageenan injection model of 
orofacial pain. Mice that received facial carrageenan injection showed increased 
mechanical allodynia, demonstrated by increased responses to von Frey hair 
stimulation of the face. The brainstem was harvested at 3 days post-injection, 
corresponding to the time of peak responses, and analyzed by Affymetrix Mouse 
Genome 430 2.0 microarrays. Large number of genes were up or down regulated in 
the brainstem after carrageenan injection, but the number of genes that showed 
common change after  right or left sided facial carrageenan injection were relatively 
small. The common genes were then classified and analysed by using Database for 
Annotation, Visualization, and Integrated Discovery (DAVID) software (Dennis et al., 
2003).   Most of them were upregulated and the largest group of genes was in the 
category of “host defence genes against pathogens”. These include chemokine, 
inflammation related, and endothelial related genes. Of these, increased expression of 
P-selectin, ICAM-1 and CCL12 after carrageenan injection could be verified by real-
time RT-PCR on both the right and left sides, and the increases in P-selectin and 
ICAM-1 further verified by Western blot analysis and immunohistochemistry. CCL12 
is closely related to human MCP-1/CCL2 in structure and may contribute to a 
signalling system that might cause neuronal hyperexcitability. ICAM-1 is an 
immunoglobulin like cell adhesion molecule that binds to leukocytes. It recruits 
immunocytes containing opioids to facilitate the local control of inflammatory pain. P-
selectin is a marker for platelet activation and endothelial dysfunction. P-selectin 
mediates the capturing of leukocytes from the blood stream and rolling of leukocytes 
along the endothelial surface. It is hypothesize that increased nociceptive input to the 
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brainstem could attract circulating macrophages into the brain, resulting in 
neuroinflammation and pain. The present findings suggest that CCL12, ICAM-1, and 




LIST OF TABLES 
Table no                              Title  Page 
Table 1 Responses scoring system. 42 
Table 2 Method of  anaesthesia. 44 
Table 3 
Average responses (no of face strokes) and standard deviation 
of right treated and right control mice. 
53 
Table 4 
Average responses (no of face strokes) and standard deviations left 
treated   and left control mice. 
54 
Table 5 








 Real time RT- PCR analysis: Fold changes in common genes 




Real time RT- PCR analysis: Fold changes in common genes 










LIST OF FIGURES 
Figure no                                     Title Page 
Figure 1 Distribution of the branches of Trigeminal nerve. 18 
Figure 2 P-selectin lectin chain. 31 
Figure 3 Lateral view of the mouse brain. 45 
Figure 4 A mouse brainstem. 48 
Figure 5 
Responses to von Frey hair stimulation of the face after tissue 




Responses to von Frey hair stimulation of the face after tissue 




Responses to von Frey hair stimulation of the face after tissue 




Responses to von Frey hair stimulation of the face after tissue 




Real time RT-PCR analysis of changes in common genes, P-
selectin, ICAM-1, and CCL12 in the mouse brainstem after 




Real time RT-PCR analysis of changes in common genes, P-
selectin, ICAM-1, and CCL12 in the mouse brainstem after 
facial carrageenan injection. Left sided carrageenan injection. 
65 
Figure 11 
Light micrographs of sections of the spinal trigeminal 
nucleus after right sided facial carrageenan injection. 
67 
Figure 12 
Ratio of densities of P- selectin on the right side of the 
brainstem, compared to the left side. 
68 
Figure 13 
Ratio of densities of ICAM-1 on the right side of the 
brainstem, compared to the left side. 
69 
Figure 14 
(A and B) Western blot analysis of homogenates of the 






Quantification of western blots. P-selectin and ICAM-1 
bands were normalized to β-actin. 
71 
Figure 16 
Hypothetical interaction of neuronal activity, blood vessels and 





















AMPA  α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate 
ANOVA  Analysis of varience 
ATP  Adenosine triphosphate 
BBB  Blood brain barrier 
BDNF  Brain-derived neurotrophic factor 
cAMP  Cyclic adenosine monophosphate 
CCL12  Chemokine (C-C motif) ligand-12 
CCL2   Chemokine (C-C motif) ligand -2 
CCL-5               Chemokine (C-C motif) ligand-5 
CCR  Chemotactic cytokine receptor 
CGRP  Calcitonin gene related peptide 
CNS  Central nervous system 
COX- 2  Cyclooxygenase-2 
DAB  Diamino benzidine tetra hydrochloride 
DAVID  Database for Annotation, Visualization, and Integrated  Discovery  
DNA Deoxyribo nucleic acid    
EDTA  Ethylene diamine tetraacetic acid 
IASP  International Association for the Study of Pain 
ICAM-1  Intercellular adhesion molecule- 1 
IgG Immunoglobulin G 
IL -1b                Interleukin-1b 
IL-6                   Interleukin-6 
8 
 
αLβ2                 Alpha L beta 2 
LFA-1               Lymphocytes function- associated antigen-1 
MAC-1             Membrane attack complex type-1 
MARK  Mitogen-activated protein kinase 
MCP                  Monocytes chemoattractant  protein 
mRNA               messenger ribo-nucleic acid  
NGF Nerve growth factor 
NMDA         N-methyl-D-aspartate                                     
NO  Nitric oxide 
NOS Nitric oxide synthase 
NS  Nociceptive specific 
PBS- TX  Phosphate buffered saline – triton 
PCGEM  Parametric test based on cross gene error model 
PG  Prostaglandin 
PKC                  Protein kinase C 
PSGL-1             P-selectin glycoprotein ligand-1      
PVDF  Polyvinylidene difluoride 
qPCR                Quantatitive polymerase chain reaction 
RT-PCR            Real-time polymerase chain reaction 
Slep  P- selectin 
SP Substance P 
TBS Tris buffered solution 
TNF-alpha        Tumour necrosis factor – alpha 
VBSNC  Trigeminal brainstem sensory nucler complex 
9 
 
VCAM Vascular cell adhesion molecule 


























Pain is defined by the “International Association for the Study of Pain” (IASP) as 
"an unpleasant sensory and emotional experience associated with actual or potential 
tissue damage, or described in terms of such damage". The World Health Organisation 
has defined pain as “an unpleasant sensory or emotional experience associated with 
actual or potential tissue damage, or described in term of such damage (Last updated 
Oct 19, 2007). 
So as a brief, pain can be defined as an unpleasant sensation that can range from 
mild, localized discomfort to agony. Pain has both physical and emotional 
components. The physical part of pain results from nerve stimulation. Pain may be 
contained to a discrete area, as in an injury, or it can be more diffuse, as in disorders 
like –fibro myalgia (Cimen et al., 2009). 
It is a major symptom in many medical conditions, which significantly interferes 
with a person‟s quality of life and general functions. This is a subjective experience, 
one difficult to measure or quantify but one having great interest regarding which 
therapy should be applied as well as its effectiveness (Garralda and Saez, 2009). 
According to duration, intensity, type (dull, burning, or stabbing), source, or 
location in the body, pain can be characterized in various ways. Diagnosis of the 
diseases also depends on the pain characters. The pain which is immediate and short 
in duration, and mostly results from disease, inflammation, or injury to tissues, is 
known as acute pain. Chronic pain is continuous pain that persists and beyond the 
time of normal healing. It ranges from mild to severe and can last for weeks, months, 
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or years to a life time. Studies have shown that the pathophysiology of chronic pain 
shows alterations of normal physiological pathways, giving rise to hyperalgesia or 
allodynia (Riedel and Neeck, 2001) 
The study of pain has in recent years attracted many different fields such as 
pharmacology, neurobiology,dentistry etc. Pain medicine is now a separate 
subspecialty figuring under some medical specialties like anaesthesiology and 
neurology. 
NOCICEPTION 
Nociception refers to the noxious stimulus originating from the sensory receptor. 
This information is carried into the central nervous system (CNS) by the primary 
afferent neuron. 
Pain sensation is perceived in the cortex, usually as a result of incoming 
nociceptive input. Nociceptive input does not always relate closely to pain. CNS has 
the ability to alter or modulate nociceptive input before it reaches the cortex for 
recognition. Modulation of nociceptive input can either increase or decrease the 
perception of pain (Okeson, 2005). 
A recent Study has shown that  the physiology of nociception involves a complex 
interaction of peripheral and central nervous system structures, extending from the 
skin, the viscera and the musculoskeletal tissues, then integration in the spinal cord 
and information is transferred to thalamus before reaches to the somatosensory 
(cerebral) cortex (Riedel and Neeck, 2001). The same study also shows that 
modulation of nociception occurs at all levels of the neuraxis. The N-methyl-D-
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aspartate (NMDA) and opioid receptor systems are the two most important systems 
for the modulation of nociception. Moreover, antinociception show a close 
distribution pattern in nearly all CNS regions, and activation of NMDA receptors has 
been found to contribute to the hyperalgesia associated with nerve injury or 
inflammation (Riedel and Neeck, 2001). 
The afferents that terminate in the spinal trigeminal nucleus contain neuropeptides 
and amino acids (such as, SP, glutamate), and the gas nitric oxide are the excitatory 
neurotransmitters in central nociceptive transmission (Sessle, 2000) 
PAIN HYPERSENSITIVITY 
Increased sensitivity of pain pathways is known as pain hypersensitivity. Two 
mechanism are known to be in pain hypersensitivity- peripheral and central 
sensitization. Sensitization here means an increase in the excitability of neurons, 
thereby becoming more sensitive to stimuli or sensory inputs. 
PERIPHERAL SENSITIZATION 
Peripheral sensitization is a reduction in threshold and an increase in 
responsiveness of the peripheral ends of nociceptors, the high-threshold peripheral 
sensory neurons that transfer input from peripheral targets such as skin, muscles, 
joints and the visceras, though peripheral nerves to the CNS  ( Woolf and Scholz, 
2000) 
Around the site of tissue damage or inflammation, sensitization arises due to the 
action of inflammatory chemicals or mediators, such as ATP, can directly activate the 
ends of the peripheral nociceptors, signalling the presence of inflamed tissue and 
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producing pain (Woolf et al., 2001).A recent study shows that peripheral inflammation 
increased the synaptic expression of NMDA receptors in the dorsal horn of the spinal 
cord (Yang et al., 2009). 
CENTRAL SENSITIZATION 
Central sensitization is an increase in the excitability of neurons within the central 
nervous system, so that normal inputs begin to produce abnormal responses. 
Central sensitization also has two phases: 
 An immediate but relatively transient phase, which depends on changes to 
existing proteins, and 
 A slower onset but longer-lasting phase, which relies on new gene expression. 
The early phase reflects changes in synaptic connections within the spinal cord, 
after a signal has been received from nociceptors. The central terminals of the 
nociceptors release a host of signal molecules, including the excitatory amino acid 
synaptic transmitter glutamate, neuropeptides (SP and calcitonin gene-related peptide, 
CGRP) and synaptic modulators including brain-derived neurotrophic factor  
(BDNF) (Woolf, 2000). 
It is likely that NMDA receptors play a role in central sensitization. Influx of 
calcium ions through the NMDA receptor could result in increased activation of 
calcium dependent kinase, resulting in increased phosphorylation of AMPA (α-amino-
3-hydroxyl-5-methyl-4-isoxazole-propionate) receptors, and increased efficacy of 
synaptic transmission between primary and secondary neurons in the pain pathway, 
resulting in hyperalgesia. Central sensitization might also be due to changes in AMPA 
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receptors density on the post-synaptic membrane or increased synaptic contacts 
between primary and secondary neurons in the nociceptive pathway (Woolf and 
Thompson, 1991). 
HYPERALGESIA 
Hyperalgesia is an increased sensitivity (increased responsiveness) to pain, 
whereby noxious stimuli produce an exaggerated and prolonged pain which may be 
caused by damage to nociceptors or peripheral nerves. 
Primary hyperalgesia describes pain sensitivity that occurs directly in the 
damaged tissues. Secondary hyperalgesia describes pain sensitivity that occurs in 
surrounding undamaged tissues. 
Primary hyperalgesia is characterized by the presence of enhanced pain to heat 
and mechanical stimuli, whereas secondary hyperalgesia is characterized by enhanced 
pain to only mechanical stimuli. The changes responsible for secondary hyperalgesia 
have two different components: 
(I) A change in the modality of the sensation evoked by low – threshold 
mechanoreceptors, from touch to pain – this is known as allodynia. And 
(II) An increase in the magnitude of the pain sensation evoked by mechanical 
sensitive nociceptors (LaMotte et al., 1991; Cervero et al., 1994). 
Nociceptors sensitization and central sensitization are considered to underlie the 
development of primary hyperalgesia and secondary hyperalgesia, respectively (Urban 
and Gebhart, 1999). Increased release of SP from primary afferents (Otsuka and 
Yanagisawa, 1987, McCarson and Krause 1996) and increased expression of the 
substance P receptor, neurokinin-1 in the dorsal spinal cord have been reported after 
peripheral inflammation in rats and mice (Allen et al., 2003). SP enhances glutamate- 
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and NMDA- induced activities in spinal cord dorsal horn neurons (Liu et al., 1997). In 
addition, glutamate, acting at a spinal NMDA receptor has itself been shown to be 
involved in the development of secondary hyperalgesia (Jang et al., 2004). NMDA 
receptor activation also induces the expression of the immediate early genes c-fos 
which, in turn, could lead to changes in the expression of other genes (Ro et al., 2007), 
such as those involved in the production of NOS or PKC which are implicated in the 
maintenance of hyperalgesia(Urban and Gebhart, 1999). 
The peripheral mechanism of hyperalgesia is considered to be the result of 
nociceptors sensitization. In injured tissue bradykinin, histamine, prostaglandin (PG), 
protons and nerve growth factor are released, which are possible agents causing 
nociceptor sensitization, since blocking of these agents suppresses sensitization. 
Secondary hyperalgesia differs from primary hyperalgesia in important ways. The 
zone of secondary hyperalgesia describes the region immediately surrounding the 
injured tissue but does not include the injured tissue. Any change in pain sensation in 
this region must be due to sensitization spreading from the zone of injury or to 
changes in processing in the CNS. 
Central sensitization plays a major role in secondary hyperalgesia. Many of the 
insight acquired about secondary hyperalgesia have been gained from studies with 
capsaisin. Capsaisin is a naturally occurring vanilloid that selectively deactivates, and 
ultimately damages several types of fine sensory C and A-delta fibres. It causes 
intense pain and a large zone of secondary hyperalgesia when applied topically or 
intradermally to the skin (Simone et al., 1989). Studies by Koppert et al., (2001), 
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Klede et al., (2003), and Sang et al., (1996) also suggest that central sensitization 
plays a major role in secondary hyperalgesia. 
TRIGEMINAL NERVE 
The chief mediator of somatic sensation from the mouth and face is the fifth 
cranial nerve – the trigeminal nerve. Sensory information from the face and body is 
processed by parallel pathway in the CNS. Trigeminal nerve is the largest cranial 
nerve, which innervates the face superficially in the region forward of a line drawn 
vertically from the ears across the top of the head and superior to the level of the 
lower border of the mandible. The fifth cranial nerve is primarily a sensory nerve, but 





DISTRIBUTION OF THE TRIGEMINAL NERVE  
 It has three major branches (Figure1): 
 Ophthalmic nerve, V1. 
 Maxillary nerve, V2. 






Figure 1: Shows dermatome distribution of the branches of the Trigeminal nerve, V1; 
Ophthalmic nerve, V2; Maxillary nerve and V3; Mandibular nerve (Wikipedia).  
 
 
BRANCHES OF THE TRIGEMINAL NERVE 
Ophthalmic and maxillary nerves are purely sensory while the mandibular nerve 
has both sensory and motor functions. 
The ophthalmic nerve carries sensory information from the scalp and forehead, 
the upper eyelid, the conjunctiva and cornea of the eye, the nose (including the tip of 
the nose), the nasal mucosa, the frontal sinuses, and parts of the meninges (the dura 
mater and blood vessels). 
The maxillary nerve carries sensory information from the lower eyelid and 
cheek, the nares and upper lip, the upper teeth and gums, the nasal mucosa, the palate 




The mandibular nerve carries sensory information from the lower lip, the lower 
teeth and gums, the chin and jaw, parts of the external ear, and part of the meninges. 
The deeper structures of the orofacial region are innervated by branches of the same 
cranial nerve. 
In classical anatomy, the trigeminal nerve is said to have general somatic afferent 
(sensory) components, as well as special visceral efferent (motor) components. The 
motor branches of the trigeminal nerve control the movement of eight muscles, 
including the four muscles of mastication (Okeson, 2005). 
 
TRIGEMINAL GANGLION 
The three branches converge on the trigeminal ganglion (also called the semilunar 
or Gasserian ganglion), that is located within Meckel‟s cave, and contains the cell 
bodies of incoming sensory nerve fibres. The trigeminal ganglion is analogous to the 
dorsal root ganglia of the spinal cord, which contain the cell goodies of incoming 
sensory fibres from the rest of the body. From the trigeminal ganglion, a single large 
sensory root enters the brainstem at the level of the pons. Motor fibers pass through 
the trigeminal ganglion on their way to peripheral muscles, but their cell bodies are 
located in the motor nucleus of the fifth cranial nerve. 
A variety of peptides are known to be present in the ganglion. For humans, these 
include CGRP, SP, somatostatin, galanin and enkephalins (Del Fiacco and Quartu, 
1994). Besides the peptides, another transmitter for the trigeminal ganglion and dorsal 





The impulses carried by the trigeminal nerve enter directly into the brainstem in 
the region of the pons to synapse in the trigeminal spinal tract nucleus. This region of 
the brainstem is structurally very similar to the dorsal horn of the spinal cord. It is also 
considered as an extension of the dorsal horn and is sometimes referred to as the 
medullary dorsal horn. Trigeminal nucleus complex consists of the main sensory 
trigeminal nucleus and the spinal tract of the trigeminal nucleus. The main sensory 
trigeminal nucleus receives periodontal and some pulpal afferents.  
The spinal tract is divided into three parts: 
 Subnucleus oralis, 
 Subnucleus interpolaris, and 
 Subnucleus caudalis, which corresponds to the medullary dorsal horn.      
The subnucleus caudalis has especially been implicated in trigeminal nociceptive 
mechanism on the basis of electrophysiologic observations of nociceptive neurons. 
The subnucleus oralis appears to be a significant area of the trigeminal brainstem 




ASCENDING TRIGEMINOTHALAMIC TRACTS 
 
Trigeminal divisions V1, V2 and V3 are responsible for cutaneous innervation of 
the face.  The spinal trigeminal tract extends from C3 to the level of the trigeminal 
nerve in the midpons (which is homologous to the dorsolateral tract of Lissauer) and 
receives pain, temperature and light touch input.  Pain fibres from the spinal 
trigeminal tract terminate in the caudal third of the spinal trigeminal nucleus (pars 
caudalis), convey general somatic afferent information from the face, oral cavity and 
dura mater to the thalamus( Okeson, 2005).  It divides into two parts: 
 Ventral trigeminothalamic tract, and 
 Dorsal trigeminothalamic tract. 
Each consists of a chain of three neurons, which have their 1st order neuron in the 
sensory ganglion of cranial nerves VII, IX and X. 
OROFACIAL PAIN  
The diagnosis and treatment of facial pain remains a great challenge for oral and 
maxillofacial surgeons. The pain syndromes are classified according to the IASP 
(International Association for the Study of Pain). The pain syndromes that the 
maxillofacial surgeons most frequently confronted with are idiopathic trigeminal 
neuralgia, atypical facial pain, and temporomandibular joint pain (Claeys et al., 1992). 
Facial pain has many causes, including idiopathic factors, trigeminal neuralgia, 
dental problems, temporomandibular joint disorders, cranial abnormalities, and 
infections. The clinical diagnosis of facial pain is sometimes difficult to establish 
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because clinical manifestations commonly overlap. Therefore, a careful evaluation of 
the patient history and a thorough physical examination are essential (Yoon et al., 
2009). 
Facial pain with focal autonomic sign is mostly primary and belongs to the group 
of idiopathic trigeminal autonomic cephalalgias, but can occasionally be secondary. 
Neuralgias are often primary.  Pure facial pain is most often due to sinusitis and the 
chewing apparatus, but may also be due to a multitude of other causes (Siccoli et al., 
2006). 
The most frequent conditions that produce secondary facial pain are myofacial 
pain syndrome, sinusitis, cervical vertebral lesions, post herpetic neuralgias, malignant 
head and neck tumours and encephalic vascular lesions of the pain pathway (Ramirez 
et al., 1989). 
MECHANISM OF OROFACIAL PAIN 
The pain pathway includes the trigeminal nerve, trigeminal nucleus, thalamus and 
cerebral cortex. The sensory input from the face and orofacial region is carried by the 
fifth cranial nerve, the trigeminal nerve. The cell bodies of the trigeminal afferent 
neurons are located in the Gasserian ganglion. The impulses carried by the trigeminal 
nerve enter directly into the brainstem in the region of the pons to synapse in the 
trigeminal spinal tract nucleus (Okeson, 2005). This region of the brainstem is 
structurally very similar to the dorsal horn of the spinal cord. Trigeminal nucleus 
complex consists of the main sensory trigeminal nucleus and the spinal tract of the 
trigeminal nucleus. Impulses then convey to the cerebral cortex via thalamus. 
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Study shows that small-diameter nociceptive afferents, such as, A-delta or C 
nerve fibres (free nerve endings) respond to craniofacial noxious stimuli, project to the 
trigeminal (V) brainstem complex where they can excite nociceptive neurons, 
[categorized as either nociceptive-specific (NS) or wide dynamic range (WDR)]. 
These neurons project to other brainstem regions or to the contralateral thalamus. The 
lateral and medial thalamus contains NS and WDR neurons which have properties and 
connections with the overlying cerebral cortex or other thalamic regions (Sessle, 
1999). 
A review study shows that the trigeminal brainstem sensory nuclear complex 
(VBSNC) plays a crucial role in craniofacial nociceptive transmission (Sessle, 2000). 
Impairment of the trigeminal nociceptive system due to demyelination and/or axonal 
dysfunction on the symptomatic side (locate this defect close to the root entry zone in 
the brainstem) in patient with trigeminal neuralgia (Obermann et al., 2007). 
A recent study shows that glutamate and capsaicin have effects on trigeminal 
nociception, activation and peripheral sensitization of deep craniofacial nociceptive 





OROFACIAL PAIN AND GENE EXPRESSION  
            Inflammation of the peripheral  tissues show increased spontaneous and 
evoked activity (Menetrey and Besson, 1982; Calvino et al., 1987; Schaible et al., 
1987), decreased thresholds to noxious stimulation (Menetrey and Besson, 1982; 
Hylden et al., 1989; Neugebauer and Schaible, 1990), and enlarged receptive fields 
(Calvino et al., 1987; Neugebauer and Schaible,1990) caused by sensitization of spinal 
cord sensory cells (Menetrey and Besson, 1982; Calvino et al., 1987;  Schaible et al., 
1987).  
Tissue injury is followed by initiation of various inflammatory mediators and 
hyperalgesic substances such as PGs (Chichorro et al., 2004), cytokines and 
chemokines (Cunha et al., 2008). These tissue injuries integrate the release of 
mediators and hyperalgesic substances, which initiate inflammatory response which is 
also associated with sensitization of nociceptors and subsequent changes in the 
excitability of the central neurons and provoke central sensitization. Nociceptors 
sensitization and central sensitization are considered to underlie the development of 
primary hyperalgesia and secondary hyperalgesia respectively (Urban and Gebhart, 
1999). Recent findings have identified a CNS neuroimmune response that may play a 
major role in neuronal hypersensitivity. Neuroimmune activation involves the 
activation of non-neuronal cells such as endothelial and glial cells, which when 
stimulated leads to enhanced production of a host of inflammatory mediators 




In tissue injury, microglia has an important role in the genesis of enhanced 
nociceptive behaviour (Yeo et al., 1995). An increase in the expression of the 
microglial marker OX42 (monoclonal antibody) has been shown in the spinal cord 
after formalin injection in the hind paw (Fu et al., 1999). Increased OX42 
immunostaining has also been found in the spinal trigeminal nucleus after facial 
formalin injection in rats (Yeo et al., 2001).  
In terms of inflammatory pain, it was known that glial cells can release a variety 
of algesic substances that may enhance pain transmission by neurons (Sommer, 2003; 
Watkins and Maier, 2003). These include proinflammatory cytokines such as inter 
leukin- 1b (IL- 1b), IL-6 and tumour necrosis factor alpha (TNF-α) (Raghavendra et 
al., 2004), chemokines such as CC-chemokine ligand-5 (CCL-5) and CCL-2 (Chan et 
al., 2006), cyclooxygenase (COX) products (Marriott et al., 1991; Stella et al., 1994) 
and NO (Simmon et al., 1992; Agullo et al., 1995). Chemokines are not stored within 
the cells but are synthesized in response to a variety of agents, including 
proinflammatory cytokines (Furie et al., 1995). IL-6 plays an important role in 
controlling leukocyte recruitment pattern during acute inflammation (Hurst et al., 
2001). IL-6 secretion is in turn induced by many other inflammatory mediators 
including IL-1β, TNF-α and PGE2. IL-6 itself induces the release of chemokines 
CCL-2 and IL-8 (Rittner et al., 2006). Inhibition of microglia by p38 mitogen-
activated protein kinase (MAPK) inhibitors (Svensson et al., 2003) or minocycline 
(Cho et al., 2006) resulted in attenuation of hyperalgesia, after intradermal or 
intraplantar injection of formalin in rats. 
         It was found that chemokines such as CCL-5 and CCL-2 (Chan et al., 2006) 
are present in the CNS neuroimmune cascade that ensues after injury to peripheral 
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nerves, and CCL-2 is a key mediator of microglial activation in neuropathic pain 
states (Thacker et al., 2008). Chemokines are synthesized at the site of injury and 
establish a concentration gradient through which immune cells migrate. Central 
sensitization through activation of immune mediators, and macrophage traffic across 
the blood-brain barrier are thought to play a key role in the development and 
maintenance of radicular pain (Rutkowski et al., 2002b) and morphine tolerance or 
withdrawal-induced hyperalgesia (Raghavendra et al., 2002). Moreover, it was 
demonstrated that microglial Toll-like receptor 4 and MAPK pathway are critical for 
glial control of neuropathic pain (Tanga et al., 2005, Suter et al., 2007). Besides 
attracting or activating glial cells, chemokines may also contribute directly to 
nociception (Boddeke, 2001). 
       Vascular endothelium also plays an important role by promoting inflammation 
through upragulation of adhesion molecules such as intercellular adhesion molecule 
(ICAM), E-selectin, and P-selectin that bind to the circulating leukocytes and facilitate 
migration of leukocytes into the CNS. Leukocytes can produce cytotoxic molecules 
that promote cell death (Wen et al., 2006). Peripheral inflammatory pain increases 
blood-brain barrier permeability and altered expression of tight junction protein such 
as ICAM-1 in endothelial cells of the thalamus and cortex (Huber et al., 2006). 
Increased expression of ICAM and VCAM, both indicators of endothelial activation, 
and increased migration of S100A8 and S100A9 expressing neutrophils into the spinal 
cord have also been detected after carrageenan-induced inflammation of rat hind paw 
(Mitchell et al., 2008). Peripheral carrageenan injection shows rapid induction of 
COX-2 expression in vascular endothelial cells in the CNS (Ibuki et al., 2003). 
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 MICROARRAY ANALYSIS 
Massive data acquisition technologies, such as genome sequencing, high-
throughput drug screening, and DNA arrays are in the process of revolutionizing 
Biology and Medicine. A microarray provides an unprecedented capacity for whole 
genome profiling.  
DNA microarrays have been used to examine changes in coding mRNA in a wide 
variety of pathological conditions. Besides coding mRNA, there is also much recent 
interest in the role of small, non-coding, micro RNA (miRNA) in regulating gene 
expression. 
Using the mRNA of a given cell, at a given time, under a given set of conditions, 
DNA microarrays can provide a snapshot of the level of expression of all the genes in 
the cell. Such snapshots can be used to study fundamental biological phenomena such 
as development or evolution, to determine the function of new genes, to infer the role 
that individual genes or group of genes may play in diseases, and to monitor the effect 
of drugs and other compounds on gene expression. The quality of gene expression 
data obtained from microarrays can vary greatly with platforms and procedures used 
such as Real – Time qPCR- the Gold Standard for Validation (Morey et al., 2006). 






CRITICAL STEPS IN MICROARRAY ANALYSIS OF GENE EXPRESSION AND 
VALIDATIONS 
STEP 1: MICROARRAY BENCHWORK: 
1. Sample collection, RNA isolation 
2. RNA quality control ( Bioanalyzer ) 
3. RNA to Biotin –labelled cRNA 
4. GeneChip hybridization (e.g. Affymetrix Platform ) 
5. Gene Chip quality control 
STEP 2: PREPROCESSING (GCOS) 
1. Detection call 
2. Signal intensity 
3. Normalization 
4. Array concordance (GENESIFTER Intensity plots) 
STEP 3: COMPUTATIONAL BIOLOGY  
(SPOTFIRE, GENESHIFTER, GENESPRING, PARTEK) 
1. Analysis of variance (ANOVA- 1 WAY) 
2. False Discovery Rate of 5%, Benjamini and Hochberg (1995). 
3. Post  - Hoc Test 
STEP 4: DATA MINING AND FILTERING  
(SPOTFIRE, GENESIFTER, GENESPRING, PARTEK etc) 
1. Heat Maps ( Visualization tool) 
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2. Scatter Plots 
3. Hierachical Clustering (Sample wise, Gene wise) 
4. Principal Component Analysis 
5. Venn Diagrams 
STEP 5: BIOLOGICAL INTEPRETATION AND VALIDATION 
Real-Time qPCR which is the Gold Standard for Validation (Morey et al., 2006). 
 
REAL-TIME POLYMERASE CHAIN REACTION 
In molecular biology, real time polymerase chain reaction (PCR), also called 
quantitative real time polymerase chain reaction (q-PCR) or kinetic PCR, is a 
laboratory technique based on the PCR, which is used to amplify and simultaneously 
quantify a targeted DNA molecule. It enables both detection and quantification of a 
specific sequence in a DNA sample. 
Real Time PCR is one of the most sensitive and reliably quantitative methods for 
gene expression analysis. 
The procedure follows the general principle of PCR; its key feature is that the 
amplified DNA is quantified as it accumulates in the reaction in real time after each 
amplification cycle. Two common methods of quantification are:  
(1) The use of fluorescent dyes that intercalate with double-stranded DNA, and  




Cells in all organisms regulate gene expression and turnover of gene transcripts 
(messenger RNA, abbreviated to mRNA), and the number of copies of an mRNA 
transcript of a gene in a cell or tissue is determined by the rates of its expression and 
degradation. 
There are numerous applications for real-time PCR in the laboratory. It is 
commonly used for both diagnostic and basic research. Diagnostic real-time PCR is 
applied to rapidly detect nucleic acids that are diagnostic of infectious diseases, 
cancer, and genetic abnormalities. The introduction of real-time PCR assays to the 
clinical Microbiology laboratory has significantly improved the diagnosis of 
infectious diseases (Sails, 2009).  
In research settings, real-time PCR is mainly used to provide quantitative 
measurements of gene transcription. The technology may be used in determining how 
the genetic expression of a particular gene changes over time, such as the response of 
tissue and cell cultures to an administration of a pharmacological agent, progression of 





P-Selectin are single chain transmembrane glycoproteins (Figure 2) which share 
similar properties to c-type lectins due to a related amino terminus and calcium-
dependent binding (Cleator, 2006). 
                                 Figure 2: P-selectin lectin chain (Wikipedia) 
During an inflammatory response, stimuli such as histamine and thrombin cause 
endothelial cells to mobilize P-selectin from stores inside the cell to the cell surface.  
As the leukocyte rolls along the blood vessel wall, the distal lectin-like domain of 
the selectin binds to certain carbohydrate groups presented on proteins (such as PSGL-
1) on the leukocyte, which slows the cell and allows it to leave the blood vessel and 
enter the site of infection (Aplin and Howe, 1998). The low-affinity nature of selectins 
is what allows the characteristic "rolling" action attributed to leukocytes during the 
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leukocyte adhesion cascade (Dept of Biomedical Engineering, University of Virginia. 
"Inflammation: The Leukocyte Adhesion Cascade).  
P-selectin is a marker for platelet activation (Makin et al., 2003), as well as a 
marker for endothelial dysfunction (Krska et al., 2003). P-selectin found stored in the 
Weibel-palade bodies of endothelial cells and in the membranes of the α-granules of 
platelets (Stenberg et al., 1985; McEver et al., 1989). Endothelial cells express lectins 
that interact with leukocyte counter receptors and mediate the initial adhesion of 
leukocytes and their rolling along endothelial surfaces (Robinson et al., 1999).     
Upregulation of P-selectin by vascular endothelium promotes inflammation by 
binding to circulating leukocytes, thus facilitating their migration into the CNS 
(Danton et al., 2003). A recent study has shown that expression of P-selectin was 
upregulated on vascular endothelium of inflammed lymph nodes and subcutaneous 
paw tissues (Mousa et al., 2000). P-selectin receptors express on T-lymphocytes bind 
to endothelial cells by a specific interaction with P-selectin in vitro (Machelska  et al., 
1998). P-Selectin also plays a role in the recruitment of β-endorphin containing 
immunocytes into inflammed subcutaneous paw tissues (Mousa et al., 2000). 
 
CHEMOKINE (C-CMOTIF) 12 
Chemokines are large family of cytokines, or proteins secreted by cells that 
control the recruitment of leukocytes in immune and inflammatory responses (Sarafi 
et al., 1997). Their name is derived from their ability to induce directed chemotaxis in 
nearby responsive cells, they are therefore called chemotactic cytokines. 
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Some chemokines are considered pro-inflammatory and can be induced during an 
immune response to promote cells of the immune system to the site of infection, while 
others are considered homeostatic and are involved in controlling the migration of 
cells during normal processes of tissue maintenance or development. These proteins 
exert their biological effects by interacting with G protein linked transmembrane 
receptors called chemokine receptors that are selectively found on the surfaces of their 
target cells. The main sources of chemokine release are from astrocytes and 
microglia/macrophages (Flugel et al., 2001). 
The major role of chemokines is to guide the migration of cells like lymphocytes. 
Cells that are attracted by chemokines follow a signal of increasing chemokine 
concentration towards the source of the chemokine. Some chemokines are 
inflammatory and functions mainly as chemoattractants for leukocytes, monocytes, 
neutrophils and other effectors cells from the blood. 
Chemokines are not only found in the immune system or expressed in 
inflammatory condition, but also present in the brain in both glial cells and neurons. 
Chemokine have several character, that define neurotransmitter, they modify the 
induce release of neurotransmitters or neuropeptides and they might act as 
neurotransmitter or neuromodulators and can cross the blood brain barrier (Rostene et 
al., 2007). 
Chemokine (c-c motif) ligand 12 (CCL-12) is a small cytokine belonging to the 
CC chemokine family that has been described in mice. CCL-12 specifically attracts 
eosinophils, monocytes and lymphocytes (Jia et al., 1996). CCL-12 also known as 
monocyte chemoattractant protein–5 (MCP – 5) is most closely related to human 
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chemokine MCP – 1/CCL-2 in structure (66% amino acid identity) (Sarafi et al., 
1997). Thus function of CCL-12 and CCL-2 are assumed to be similar. CCL-2 is a 
ligand for chemotactic cytokine receptor 2 (CCR-2) (Moore et al., 2006).          
 
INTERCELLULAR ADHESION MOLECULE 1 (ICAM- 1) 
Intercellular adhesion molecules (ICAMs) are proteins located on the cell surface 
involved with the binding with other cells or with the extracellular matrix in the 
process called „cell adhesion‟. These proteins are typically transmembrane receptors 
and are composed of three domains: 
 An  intracellular domain that interacts with the cytoskeleton, 
 A transmembrane domain, and 
 An extracellular domain 
ICAM-1 is an immunoglobulin-like cell adhesion molecule that binds to 
leukocyte beta-2 integrin (Miklossy et al., 2006). Endothelial ICAM-1 interacts with 
LFA-1 and Mac-1, and mediates leukocyte adherence, transendothelial migration and 
movement of activated lymphocytes into sites of inflammation (Miklossy et al., 2006). 
ICAM-1 also plays an important role in immune-mediated cell to cell adhesive 
interactions, intracellular signal transduction pathways through outside-in signalling 
events and may play a primary role in regulating blood brain barrier (BBB) function 
and structure (Huber et al., 2006). ICAM-1 is also a marker for endothelial 
dysfunction (Krska et al., 2003) and systemic inflammation (Mateos-Cáreres et al., 
2002). A recent study has shown that expression of ICAM-1 on vascular endothelium 
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recruits immunocytes containing opioids to facilitate the local control of inflammatory 
























     AIMS OF THE PRESENT STUDY 









The aims of the project were: 
(a) To evaluate the gene expression changes that occur in the brainstem after 
facial carrageenan injection in a mouse model of orofacial pain, by DNA 
microarray analysis (Affymetrix Mouse Genome 430 2.0 microarrays), 
(b) To identify differential changes in coding mRNA in the spinal trigeminal 
nucleus / brainstem after facial carrageenan induced hyperalgesia and validate 
the findings by RT-PCR, immunohistochemistry and Western blot analysis. 
Also to evaluate differential changes in micro RNA, and 
(c) To examine a possible relation between changes in micro RNA and mRNA in 
the spinal trigeminal nucleus / brainstem after facial carrageenan induced 
hyperalgesia. Genes that might be involved in pain can be targeted to reduce 



























Animals in the present study were cared for and treated according to the ethical 
standards and guidelines for investigations of experimental pain in animals prescribed 
by the Committee for Research and Ethical Issues of the International Association for 
the Study of Pain (IASP 1983). 
All procedures involving the mice were reviewed and approved by the 
Institutional Animal Care and Use Committee (IACUC) of the National University of 
Singapore (NUS), and adhered to the guidelines of the Committee for Research and 
Ethical Issues of IASP.  
ANIMALS 
Twenty-four adult male C57BL/6J (B6) mice, about 6-8 weeks of age and 
weighing   approximately 20-30 g at arrival were purchased from the Laboratory 
Animal Centre, Singapore. The mice were housed in stainless steel cages (4 mice per 
cage) in the animal house with an ambient temperature water and food were available 
ad libitum. Each mice will be subjected to facial carrageenan injection and behavior 
testing done for the next 3 days after injection before harvesting  the brainstem.  
The mice were randomly divided into three groups,  
 Right treated 




Considering the discomforting disorder, the number of animals restricted to the 
bare minimum necessary, average of eight mice per group was used. The treated 
groups were injected with carrageenan on the facial area-i.e. the trigeminal nerve 
distribution area.  
Refinement of procedures had been fine-tuned to the best of abilities because the 
procedure had been carried out on several occasions. Every effort was made to treat 
the animal humanely. However, using of analgesics and sedatives to reduce stress and 
pain of animals after facial injection was avoided because it may affect the test results. 
All mice were labelled with a coded number tag on their tails, to allow the behavioural 
responses of an individual mouse to be followed at different time intervals. 
FACIAL CARRAGEENAN INJECTION 
All the treated mice received a facial injection of 50 µl carrageenan (2 mg / 50 µl 
saline of lambda carrageenan, Sigma) in the subcutaneous tissue over the right/left 
trigeminal nerve distribution area – ophthalmic, maxillary and mandibular regions, 
while the mice were still under anaesthesia. The injection of carrageenan produced a 
constant swelling and caused allodynia in the injected area in the days following the 







ASSESSMENT OF RESPONSES TO MECHANICAL STIMULATIONS 
The testing procedure consisted of assessment of the animal‟s responses to 
mechanical stimulation of the face. The mice were assessed for responses to von Frey 
hair stimulation of the face before injections, and from day 1 to day 3 after injections 
(Yeo et al,). All assessment procedures were carried out in a blinded manner and this 
method has been quoted to be a good model for pain study in contrast to itch (Shimada 
and Lamotte, 2008). 
STIMULUS 
For mechanical stimulation a von Frey hair (Touch- Test Sensory Evaluator, 
North Coast Medical, Morgan Hill, USA) was used. The von Frey hair consisted of 
plastic monofilament of length 4 cm delivering a force required to bend was 
approximately 1.4 gm (or converted to log units 4.17 log units). The test stimulus was 
applied over the subcutaneous tissue of the right and left maxillary region. Pilot 
observations showed that each stimulus evoked a behavioural response when applied 
to the face of normal animals. 
TESTING PROCEDURES 
To observe the response to mechanical stimulations, all the mice were tested 
individually in a deep rectangular stainless steel tank (60cm×40cm×25cm= 
60000cm³). Before the actual stimulation session began, the mice were habituated to 
the tank for at least 5-10 min.  The experimenter reached into the tank with a von Frey 
hair to habituate the mice to the reaching movements for 5–10 min before testing. The 
mice were observed during this time, to ensure that they were able to move freely, and 
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had no obvious motor deficits. After the mice were adapted, a series of mechanical 
stimuli were started.  The test stimulations were administered when the mice were in a 
no locomotion state, with four paws placed on the ground, neither moving nor 
freezing, but exhibiting sniffing behaviour. A new stimulus was applied only when the 
mouse resumed this position and at least 30 secs after the preceding stimulation. The 
carrageenan injected area of the face was probed 20 times with the von Frey hair 
filament. The response scoring procedure used in this study has been modified from 
Vos et al, 1994 (Table 1). 
 







Detection Withdrawal Escape/Attack Grooming 
No response 0 0 0 0 
Non-aversive 
response 
1 0 0 0 
Mild-aversive 
response 
1 1 0 0 
Strong-aversive 
response 
1 1 1 0 
Prolong-aversive 
behaviour 
1 1 1 1 
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CATEGORIES OF RESPONSE 
The number of any immediate response exhibited by the mouse after each 
stimulation, was recorded in each of the following four categories as previously 
described (Vos et al., 1994) 
 (1) Detection: Mouse turns head toward stimulating object, and the stimulating 
object is then explored (sniffing, licking), 
 (2) Withdrawal reaction:  Mouse turns head slowly away or pulls it briskly 
backward when stimulation is applied,  
(3) Escape/Attack: Mouse avoids further contact with the stimulating object, 
either passively or actively by attacking (biting or grabbing movements) the 
stimulating object, 
 (4) Asymmetric face grooming/scratching: Mouse displays an uninterrupted 
series of face-wash strokes directed to the stimulated facial area. Each stroke was 
counted as one response.  
The number of face grooming / scratching was totalled, to give the „total 
responses‟ after 20 stimulations with the von Frey hair. The mean and standard 
deviation of the total responses were then calculated for each treatment group, and the 
significant differences between the means elucidated using independent t-test. P < 





METHOD OF ANAESTHESIA 
   The agent, dose, volume and route of administration in the mice species given 
below (Table 2): 









 1 mg/kg 




Table 2: Method of anaesthesia. 
 
MICROARRAY DATA COLLECTION GENE EXPRESSION 
The portion of the brainstem containing the spinal trigeminal nucleus (Figure 3) 
i.e. relay neurons for nociception from the orofacial region, was dissected out from 
carrageenan-injected- and control mice with the help of a scalpel, with reference to an 




Figure 3: Lateral view of a mouse brain. The extent of the spinal trigeminal nucleus is 
delimited by the vertical lines (Paxinos and Franklin, 2001). 
 
 
 Gene expression profiles of brainstem tissue isolated from carrageenan injected 
mice and control mice were compared using Affymetrix Mouse Genome 430 2.0 
microarrays (Affymetrix, CA, USA). Total RNA was isolated using TRIzol reagent 
(Invitrogen, CA, USA) according to the manufacturer's protocol, and RNeasy® Mini 
Kit (Qiagen, Inc., CA, USA) was used to clean up the RNA. The RNA was stored at -
80 °C. Total RNA was then submitted to the BFIG Core Facility Lab (National 
University of Singapore, Department of Paediatrics), where RNA quality was 
analyzed using an Agilent 2100 Bioanalyzer, and cRNA was generated and labelled 
using the one-cycle target labelling method, cRNA from each mouse was hybridized 
to a single array according to standard Affymetrix protocols. 
Altogether, total of sixteen microarrays were used – four for the right brainstem 
of mice receiving right sided facial carrageenan injection, four for the right side of 
untreated controls, and similarly for the left brainstem of mice receiving left sided 
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facial carrageenan injection and corresponding controls. Initial image analysis of the 
microarray chips was performed with Affymetrix GCOS 1.2 software. The data were 
exported into GeneSpring v7.3 (Agilent Technologies, CA, USA) software for 
analysis using parametric test based on cross gene error model (PCGEM). One-way 
ANOVA approach was used to identify differentially expressed genes. Differentially 
expressed genes were then classified based on their known biological functions using 
the Database for Annotation, Visualization, and Integrated Discovery (DAVID) 
software (Dennis et al., 2003). 
 
REAL- TIME POLYMERASE CHAIN REACTION 
        Total RNA was isolated using TRIzol reagent (Invitrogen, CA, USA) 
according to the manufacturer's protocol, and RNeasy® Mini Kit (Qiagen, Inc., CA, 
USA) was used to clean up the RNA. The RNA was later treated with Dnase I 
(Applied Biosystems, CA, USA) according to manufacturer‟s protocol. The samples 
were then reverse transcribed using High-Capacity cDNA Reverse Transcription Kits 
(Applied Bio systems, CA, USA). Reaction conditions were 25
o
C for 10 min, 37
o
C for 
120 min and 85
o
C for 5 secs. RT-PCR amplification was then carried out in the 7500 
RT- PCR system (Applied Bio systems, CA, USA) using TaqMan® Universal PCR 
Master Mix (Applied Bio systems, CA, USA) and gene-specific primers and probes 
according to manufacturer‟s protocols. ß-actins were used as internal control, and all 
primers and probes were synthesized by Applied Bio systems. The PCR conditions 
were: an initial incubation at 50
o
C for 2 min and 95
o
C for 10 min followed by 40 
cycles at 95
o
C for 15 s and 60
o
C for 1 min. All reactions were carried out in triplicate. 
The threshold cycle, CT, which correlates inversely with the levels of target mRNA, 
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was measured as the number of cycles at which the reporter fluorescence emission 
exceeds the preset threshold level. The amplified transcripts were quantified using the 
comparative CT method as described previously (Livak and Schmittgen, 2001), with 
the formula for relative fold change = 2
–∆∆CT
. The mean was calculated and significant 
differences analysed using Student‟s t-test. P < 0.05 was considered significant. 
 
 IMMUNOHISTOCHEMISTRY OF P-SELECTIN AND ICAM-1 
 Four adult male C57BL/6J (B6) mice were used for this portion of study. The 
mice were injected with carrageenan in the facial area and sacrificed at 3 days after 
injection. The mice were deeply anesthetized and perfused through the left ventricle 
with a solution of 4% Paraformaldehyde in 0.1 M phosphate buffer (pH 7.4). The 
brains were dissected out, and blocks containing the brainstem sectioned at 40 µm 
using a freezing microtome. The sections were washed for 3 h in phosphate-buffered 
saline containing 0.1% Triton (PBS-TX) to remove traces of fixative, and immersed 
for 1 h in a solution of 5% normal rabbit serum and 1% bovine serum albumin in 
PBS-TX to block non-specific binding of antibodies. They were then incubated 
overnight with goat polyclonal antibodies to P-selectin (Selp), and intercellular 
adhesion molecule 1 (ICAM-1) (Santa Cruz, diluted 1:100). Negative controls were 
carried out by incubation with P-selectin or ICAM-1 antigen-absorbed antibodies. The 
sections were then washed three times in PBS, and incubated for 1 h at room 
temperature in 1:200 dilution of biotinylated rabbit anti-goat IgG (Vector 
Laboratories, Burlingame, USA). This was followed by three changes of PBS to 
remove unreacted secondary antibody. The sections were then reacted for 1 h at room 
temperature with an avidin-biotinylated horseradish peroxidase complex. The reaction 
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was visualized by treatment for 5 min in 0.05% 3.3-diaminobenzidine 
tetrahydrochloride (DAB) solution in Tris buffered saline containing 0.05% hydrogen 
peroxide. The colour reaction was stopped with several washes of Tris buffer. 
Sections were counterstained with methyl green before cover slipping. Light 
micrographs were captured using an Olympus BX51 microscope (Olympus 
Corporation, Tokyo, Japan). The location of the spinal trigeminal nucleus is shown in 
(Figure 4).  
 
 
Figure 4: A mouse brainstem. The spinal trigeminal nucleus is demarcated by the 
dotted line. The square box indicates the approximate region where images in figure 
11 were obtained. 
The density of staining was analysed using MetaMorph software (Fatemi et al., 
2001). The mean density was calculated and significant differences analysed using 




WESTERN BLOT ANALYSIS 
 
A further six adult male C57BL/6J (B6) mice were used for this portion of study. 
The first 3 mice were injected with carrageenan in the right side of the face and 
sacrificed 3 days after injection, while the other 3 mice were used as controls. They 
were deeply anesthetized and decapitated, a portion of the right brainstem containing 
the spinal trigeminal nucleus was removed and homogenized in 10 volumes of ice-
cold lysis buffer (150 mM sodium chloride, 50 mM Tris hydrochloride, 0.25 mM 
EDTA, 1 % Triton X-100, 0.1% sodium orthovanadate, and 0.1% protease inhibitor 
cocktail, pH 7.4). After centrifugation at 10,000 g for 10 min at 4
o
C, the supernatant 
was collected. The protein concentrations in the preparation were then measured using 
the Bio-Rad protein assay kit. The homogenates (40 μg) were resolved in 10% SDS-
polyacrylamide gels under reducing conditions and electrotransferred to a 
polyvinylidene difluoride (PVDF) membrane. Non-specific binding sites on the PVDF 
membrane were blocked by incubating with 5% non-fat milk in 0.1% Tween-20 TBS 
(TTBS) for 1 h. The PVDF membrane was then incubated overnight in polyclonal 
antibody to P-selectin (1:200) and ICAM-1 (1:200) in 1% bovine serum albumin in 
TTBS. Negative controls were carried out by incubation with P-selectin or ICAM-1 
antigen-absorbed antibodies. After washing with TTBS, the membrane was incubated 
with horseradish peroxidase-conjugated anti-goat IgG (1:2,000 in TTBS, Pierce, 
Rockford, IL) for 1 h at room temperature. Immunoreactivity was visualized using a 
chemiluminescent substrate (Supersignal West Pico, Pierce, Rockford, IL). Loading 
controls were carried out by incubating the blots at 50°C for 30 min with stripping 
buffer (100 mM 2-mercaptoethanol, 2% SDS, and 62.5 mM Tris-hydrochloride, pH 
6.7), followed by reprobing with a mouse monoclonal antibody to β-actin (Sigma; 
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diluted 1:5,000 in TTBS) and horseradish peroxidase-conjugated anti-mouse IgG 
(1:5,000 in TTBS, Pierce). Exposed films containing blots were scanned and the 
densities of the bands measured, using Gel-Pro Analyzer 3.1 program (Media 
Cybernetics, Silver Spring, MD). The densities of the P-selectin and ICAM-1 bands 
were normalized against those of β-actin, and the mean ratios calculated. Significant 
differences between the values from the carrageenan injected and control animal were 

























































PAIN RESPONSES AFTER FACIAL CARRAGEENAN INJECTION 
 
The number of face strokes after facial carrageenan injection with peak 
responses was recorded at 3 days after injection. The carrageenan injected mice in this 
experiment likewise showed increasing responses up to the third day after carrageenan 
injection (Data shown in tables 3 and 4) with significantly increased responses 
compared to control mice at post injection days 1, 2 and 3 (Figure 5, 6, 7, and 8). They 
were sacrificed on the 3
rd
 post injection day and the brainstem harvested for 
microarray analysis. Data was analysed by Student‟s t-test, P value< 0.05 was 




AVERAGE RESPONSES AND STANDARD DEVIATION OF RIGHT 
TREATED VS RIGHT CONTROL 
 
 








Table 3: Average responses (no of face strokes) and standard deviation of right treated 













Right Treated Right Control 
Average SD Average SD 
Before injection 6 0.82 8.25 1.50 
Day 1 20.25 4.35 7.75 3.40 
Day 2 23.50 3.87 6.50 1.73 
Day 3 30.75 3.30 8.75 1.71 
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AVERAGE RESPONSES AND STANDARD DEVIATIONS OF LEFT 





Table 4: Average responses (no of face strokes) and standard deviations left treated 













Left Treated Left Control 
Average SD Average SD 
Before injection 4.50 1.91 3.25 1.26 
Day 1 20 1.83 4.50 2.08 
Day 2 23.75 0.96 7 2.16 






Figure 5:  Responses to von Frey hair stimulation of the face after tissue inflammation 
induced by right sided carrageenan injection vs. right control. The Y axis represents 
number of face strokes to von Frey hair stimulation of the carrageenan injected areas 
of the face. The X axis represents the no of days; BI: before injection, 1D, 2D, 3D 
refer to 1 day, 2 days, and 3 days after injection. Red line: Untreated control. Blue 








































Figure 6: Responses to von Frey hair stimulation of the face after tissue inflammation 
induced by left sided carrageenan injection vs. left control. The Y axis represents 
number of face strokes to von Frey hair stimulation of the carrageenan injected areas 
of the face. The X axis represents the no of days ;BI: before injection, 1D, 2D, 3D 
refer to 1 day, 2 days, and 3 days after injection. Red line: Untreated control. Blue 








































Figure 7: Responses to von Frey hair stimulation of the face after tissue inflammation 
induced by right sided carrageenan injection vs. right control. The Y axis represents 
number of responses to von Frey hair stimulation of the carrageenan injected areas of 
the face. BI: before injection, 1D, 2D, 3D refer to 1 day, 2 days, and 3 days after 
injection. C: Untreated control. T: After facial carrageenan injection. Analysed by 













































Figure 8: Responses to von Frey hair stimulation of the face after tissue inflammation 
induced by left sided carrageenan injection vs. left normal. The Y axis represents 
number of responses to von Frey hair stimulation of the carrageenan injected areas of 
the face. BI: before injection, 1D, 2D, 3D refer to 1 day, 2 days, and 3 days after 
injection.  C: Untreated control. T: After facial carrageenan injection. Analysed by 











































MICROARRAY ANALYSIS  
The carrageenan injected mice in this experiment showed increasing responses up 
to the third day after carrageenan injection, with significantly increased responses 
compared to control mice at post-injection days 1, 2 and 3. They were sacrificed on 
the 3
rd
 post-injection day and the brainstem harvested for microarray analysis. 
 A total of 539 and 646 genes were found to have greater than 2-fold changes in 
the right or left halves of the brainstem, after right or left sided carrageenan injection 
compared to untreated animals. Of these, genes of uncertain ontology were ignored, 
leaving 173 and 161 known genes with more than two fold change after right or left 
sided carrageenan injection. Thereafter, identical genes resulted from both right and 
left facial carrageenan injection were identified, which helped to minimise the impact 
of false positives that could have arise by chance. This results in a relatively small list 
of genes (22 genes). Most of them showed upregulation after carrageenan injection. 
They were classified using the Database for Annotation, Visualization, and Integrated 
Discovery (DAVID) software (Dennis et al., 2003) (Table 5 and 6). Expected many of 
them fell into the categories of “response to stress”, “defence response”, “response to 
biotic stimulus”, “cell adhesion” and “leukocyte adhesion”. Five genes in common in 
these categories were selected for further validation in the present study, these were P-
selectin, ICAM-1, Chemokine (C-C) motif ligand 12 (CCL12, MCP-5), Angiogenin 4 






Table 5: Upregulated genes in the brainstem after facial carrageenan injection. These are 
genes that show up regulation by more than two folds after both right – or left sided 
carrageenan injection, compared to brainstem specimens of the same side of untreated control 







  Fold Change  





Developmental Process / 
Anatomical Structure 
Development 
Prostaglandin-endoperoxidase synthase 2 Ptgs2 13.7  6.9 6.7  2.7 
Angiogenin 4 Ang4 5.1  0.9 3.8  0.9 
Von Willebrand factor homolog Vwf 4.8  1.6 2.3  0.6 
Suppressor of cytokine signalling 3 Socs3 3.8  2.6 2.1  0.5 
Homeo box, msh-like 2 Msx2 2.9  0.6 2.2  0.7 
Anatomical / Structure 
Morphogenesis 
Angiogenin 4 Ang4 As above As above 
Von Willebrand factor homolog Vwf As above As above 
Suppressor of cytokine signalling 3 Socs3 As above As above 
Homeo box, msh-like 2 Msx2 As above As above 
Response to Stress 
Prostaglandin-endoperoxidase synthase 2 Ptgs2 As above As above 
Selectin, platelet Selp 12.3  7.2 2.6  2.4 
Chemokine (C-C motif) ligand 12 Ccl12 8.9  2.5 14.2  7.1 
Von Willebrand factor homolog Vwf As above As above 
System / Organ 
Development 
Prostaglandin-endoperoxidase synthase 2 Ptgs2 As above As above 
Angiogenin 4 Ang4 As above As above 
Von Willebrand factor homolog Vwf As above As above 
Homeo box, msh-like 2 Msx2 As above As above 
Cell Adhesion / 
Biological Adhesion 
Selectin, platelet Selp As above As above 
Von Willebrand factor homolog Vwf As above As above 
Intercellular adhesion molecule Icam1 4.5  1.4 2.8  1.3 
Defence Response 
Selectin, platelet Selp As above As above 
Chemokine (C-C motif) ligand 12 Ccl12 As above As above 
Angiogenin 4 Ang4 As above As above 
Negative Regulation of 
Cellular /  Biological 
Process 
Angiogenin 4 Ang4 As above As above 
Suppressor of cytokine signalling 3 Socs3 As above As above 
Homeo box, msh-like 2 Msx2 As above As above 
Organ Morphogenesis 
Angiogenin 4 Ang4 As above As above 
Von Willebrand factor homolog Vwf As above As above 
Homeo box, msh-like 2 Msx2 As above As above 
Response to Wounding 
Selectin, platelet Selp As above As above 
Chemokine (C-C motif) ligand 12 Ccl12 As above As above 
Von Willebrand factor homolog Vwf As above As above 
Cell-Cell Adhesion Selectin, platelet Selp As above As above 
Intercellular adhesion molecule Icam1 As above As above 
Enzyme Linked Receptor 
Protein Signalling 
Pathway 
Suppressor of cytokine signalling 3 Socs3 As above As above 
Homeo box, msh-like 2 Msx2 As above As above 
Leukocyte Adhesion Selectin, platelet Selp As above As above 
Response to Biotic 
Stimulus 
Intercellular adhesion molecule Icam1 As above As above 








Fold Change  






Sclerostin domain containing 1 Sostdc1 -2.5  0.5 -2.8  0.7 
Myosin, heavy polypeptide 1 skeletal 
muscle 
Myh1 -2.3  0.6 -8.0  0.2 
Heat shock protein 1A Hspa1a -2.1  0.3 -2.3  0.2 
Anatomical Structure / System 
/ Organ Development 
Sclerostin domain containing 1 Sostdc1 As above As above 
Myosin, heavy polypeptide 1, skeletal 
muscle 
Myh1 As above As above 
Negative Regulation of 
Cellular / Biological Process 
Sclerostin domain containing 1 Sostdc1 As above As above 
Heat shock protein 1A Hspa1a As above As above 
Response to Biotic Stimulus 
Cathelicidin antimicrobial peptide Camp -4.3  0.4 -2.8  0.6 
Heat shock protein 1A Hspa1a As above As above 
Anatomical Structure 
Morphogenesis 
Sclerostin domain containing 1 Sostdc1 As above As above 
Cell Adhesion / Biological 
Adhesion / Cell-Cell Adhesion 
Cadherin 3 Cdh3 -2.7  1.4 -3.7  0.2 
Defence Response Cathelicidin antimicrobial peptide Camp As above As above 
Organ Morphogenesis / 
Enzyme Linked Receptor 
Protein Signalling Pathway 
Sclerostin domain containing 1 Sostdc1 As above As above 
Response to Stress Heat shock protein 1A Hspa1a As above As above 
 
 
Table 6:  Down regulated genes in the brainstem after facial carrageenan injection. These are 
genes that show down regulation by more than two folds after both right – or left sided 
carrageenan injection, compared to brainstem specimens of the same side of untreated control 
mice. They are grouped into functional classes using DAVID software.  
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VALIDATION OF DIFFERENTIALLY EXPRESSED GENES IDENTIFIED 
BY MICROARRAY ANALYSIS  
 Real time RT-PCR was used to validate the results of the microarray analysis 
for the selected genes, P-selectin, ICAM-1, CCL-12, Ang4 and Camp. Only 3 genes, 
P-selectin, ICAM-1 and CCL-12 were validated. All of them showed upregulation 
after either right or left sided carrageenan injection, thus validating the results of the 
microarray analysis. 
The relative fold change (Figure 9 and 10) of P-selectin, ICAM-1 and CCL12 for the 
right treatment were 25.3, 3 and 4.30 respectively, while the relative fold change of P-
selectin, ICAM-1 and CCL12 for the left treatment were 10.80, 5.90 and 3.80 
















REAL-TIME PCR CALCULATION ( RIGHT SIDE) 
 
Genes Fold Change Stdev 
CCL12 Control 1 0.27 
CCL12 Treated 4.32 0.43 
ICAM Control 1 0.20 
ICAM Treated 3.02 0.67 
      P-selectin Control 1 1.04 
      P-selectin Treated 25.27 1.69 
 
 
Table 7: Real time RT- PCR analysis: Fold changes in common genes CCL12, ICAM-
















REAL-TIME PCR CALCULATION ( LEFT SIDE) 
 
Genes    Fold Change      St dev 
CCL12 Control 1 0.50 
CCL12 Treated 3.75 0.41 
ICAM-1 Control 1 1.37 
ICAM-1 Treated 5.90 1.51 
 P-selectin Control 1 1.11 
 P-selectin Treated 10.82 1.17 
 
Table 8:  Real time RT- PCR analysis: Fold changes in common genes CCL12, 
















Figure 9: Real time RT-PCR analysis of changes in common genes, P-selectin, ICAM-
1, and CCL12 in the mouse brainstem after facial carrageenan injection. Right sided 
carrageenan injection.  C: Untreated control. T: After facial carrageenan injection. 





 Figure 10: Real time RT-PCR analysis of changes in common genes, P-selectin, 
ICAM-1, and CCL12 in the mouse brainstem after facial carrageenan injection. Left 
sided carrageenan injection. C: Untreated control. T: After facial carrageenan 


















































IMMUNOHISTOCHEMISTRY OF P-SELECTIN AND ICAM-1   
Light staining for P-selectin was observed in the brainstem of untreated mice 
(Figure 11A). In contrast, mice that received facial carrageenan injection showed 
significantly increased density of staining compared to untreated mice (Figure 11C). 
Mice that received right facial carrageenan injection also showed increased density of 
staining compared to its contralateral side (Figure 11E). Sections which were 
incubated with antigen absorbed antibody showed absence of labelling, indicating 
specificity of the antibody (Figure 11G). 
 Likewise, light staining to ICAM-1 was observed in the brainstem of untreated 
mice (Figure 11B). In contrast, mice that received facial carrageenan injection showed 
significantly increased density of staining compared to untreated mice (Figure 11D). 
Mice that received right facial carrageenan injection also showed increased density of 
staining compared to its contralateral side (Figure 11F). Sections which were 
incubated with antigen absorbed antibody showed absence of labelling, indicating 



























Figure 11: Light micrographs of sections of the spinal trigeminal nucleus after right 
sided facial carrageenan injection. A, C and E: sections incubated with antibody to P-
selectin, showing increased staining on the blood vessels of a treated mouse (C, 
arrows), compared to an untreated control (A, arrow), and its contralateral side (E, 
arrows). G: section incubated with antigen-absorbed P-selectin antibody, showing 
absence of labelling. B, D and F: sections incubated with antibody to ICAM-1, 
showing increased staining on the blood vessels of a treated mouse (D, arrows), 
compared to an untreated control (B, arrow), and its contralateral side (F, arrows). H: 
section incubated with antigen-absorbed ICAM-1 antibody, showing absence of 
labelling. Counter-staining of methyl green (stain for nuclear) are shown in the images 
as green circular structure. Scale: A-H = 60 µm. 
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The density of staining analysed using MetaMorph software (Fatemi et al., 2001). 
The mean density was calculated and possible significant differences analysed using 





Figure 12: Ratio of densities of P- selectin on the right side of the brainstem, 
compared to the left side. The mean density was calculated and possible significant 


































Figure 13:  Ratio of densities of ICAM-1 on the right side of the brainstem, compared 
to the left side. The mean density was calculated and possible significant differences 














































WESTERN BLOT ANALYSIS OF P-SELECTIN AND ICAM-1  
The antibodies to P-selectin and ICAM-1 detected bands at around 140 kDa and 
90 kDa respectively, consistent with the expected molecular weights of these proteins 
(Walter et al., 1997; Yang et al., 1999). No band was detected in the negative control. 
The antibody to β-actin reacted against a band at 42 kDa. Significant increase in the 
density ratios of P-selectin and ICAM-1 to β-actin bands were observed in Western 
blots of the 3 days post-carrageenan-injected mice, compared to the control mice 
indicating upregulation of P-selectin and ICAM-1 at this time point. 
 
 
Figure 14: (A and B) Western blot analysis of homogenates of the brainstem for 
untreated and 3-day post-facial carrageenan injected mice. A, B: Left panels: The 
antibody to P-selectin (A) and ICAM-1 (B) detected single bands at ~140 kDa and 
~90 kDa respectively. Right panels: No bands were detected in negative controls that 















Figure 15: Quantification of western blots. P-selectin and ICAM-1 bands were 
normalized to β-actin. Significant increase in the density of detected bands was 
observed in carrageenan-injected mice, compared to untreated controls. Analyzed by 






















































The present study was carried out to examine changes in gene expression in the 
mouse brainstem after carrageenan-induced hyperalgesia. Facial injection of 
carrageenan resulted in increased nociception, as demonstrated by increased responses 
to von Frey hair stimulation. Previous studies showed that such increased responses 
peaked at about 3-4 days after injection. The brainstem was harvested 3 days after 
injection, corresponding to the peak time of hyperalgesia. Large numbers of genes 
showed two or more fold changes in the brainstem after carageenan injected mice 
compared with the controls. Mice that had been injected with carrageenan on the right 
side were compared to controls that were injected with saline on the same side, and 
likewise for the left side. The number of these genes was relatively small, with both 
sides having 22 genes in common. Most of them showed up regulation after 
carrageenan injection. The functions of the genes were classified by DAVID software 
(Dennis et al., 2003). Surprisingly, the largest groups of genes were found to belong to 
the category of host defence genes against pathogens. These include chemokine, 
inflammation related and endothelial related genes. Of the above genes, the increase in 
expression of P-selectin, ICAM-1, and CCL2 could be verified by real time RT-PCR 
on both the right and left sides. P-selectin and ICAM-1 could also be verified by 
immunohistochemistry, with significantly greater staining on endothelial cells on the 
side of the injection, compared to the opposite side, consistent with the microarray and 
RT-PCR results. In addition, difference in the number of face strokes between right 
and left facial carrageenan- injected mice seems to correlate with the difference in the 
general regulation of the genes in both right and left spinal trigeminal nucleus. Fold 
change of genes in the right facial carrageenan- injected mice seems to be up regulated 
in a higher level compared to left facial carrageenan injected mice, i.e. 12.3 fold 
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change difference in p-selectin of right facial carrageenan-injected mice compared to 
2.6 fold change difference in left facial carrageenan-injected mice, and 4.5 fold 
change difference in ICAM-1 of right facial carrageenan-injected mice compared to 
2.8 fold change difference in left facial carrageenan-injected mice. These higher 
degrees of up regulation of these genes could correlate with the increase in the number 
of face strokes. However, the reason for this difference is not known. 
P-selectin is important in macrophage adhesion to blood vessels (Danton and       
Dietrich, 2003). Endothelial cells express selectins that interact with leukocyte counter 
receptors and mediate the initial adhesion of leukocytes and their rolling along 
endothelial surfaces (Robinson et al., 1999). It was found that selectins mediate the 
initial phase of immunocytes extravasations into inflamed sites, and anti-selectin 
treatment inhibits the infiltration of immunocytes (Machelska et al., 1998). Up 
regulation of P-selectin by vasculature endothelium promotes inflammation by 
binding to circulating leukocytes, thus facilitating their migration into the CNS 
(Danton and Dietrich, 2003). ICAM-1 is a marker for endothelial dysfunction (Krska 
et al., 2003) and systemic inflammation (Foster et al., 2003). It plays an important role 
in immune-mediated cell-cell adhesive interactions, intracellular signal transduction 
pathways through outside-in signalling events and may play a primary role in 
regulating BBB function and structure (Huber et al., 2006). Upregulation of adhesion 
molecules including P-selectin, E-selectin and ICAM may enhance the migration of 
leukocytes into the CNS (Danton and Dietrich, 2003). Antibody against ICAM-1 
blocked neutrophils accumulation and thermal hyperalgesia (Foster et al., 2003). 
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      Besides endothelial markers, changes were also observed in chemokines and 
cytokines. CCL-12 also known as MCP-5, is most closely related to human MCP-
1/CCL-2 in structure (66% amino acid identity) (Sarafi et al., 1997). CCL2 is a ligand 
for chemotatic cytokine receptor 2 (CCR-2) (Moore et al., 2006). Both of these are 
involved in macrophage migration (McTigue et al., 1998). Intrathecal administration 
of MCP-1 induced mechanical allodynia, suggesting that MCP-1 has a role in the 
development of mechanical allodynia induced by nerve injury (Tanaka et al., 2004). 
MCP-1/CCR2 may also contribute to neuronal hyperexcitability and neuropathic pain 
after chronic nerve compression injury (White et al., 2005). 
 One possibility is that increased neuronal activity can cause the upregulation 
of endothelial markers in blood vessels, such as P-selectin and ICAM-1. Increased 
release of SP from primary afferents (McCarson and Krause, 1996; Otsuka and 
Yanagisawa, 1987) has been reported after peripheral inflammation in rats and mice 
(Allen et al., 2003), and it is possible that this could induce the expression of P-
selectin and ICAM-1 in brain endothelial cells. SP has been shown to induce human 
dermal microvascular endothelial cells to express P-selectin, ICAM-1 and VCAM-1, 
suggesting that it plays a role in recruiting cells to the inflamed skin (Quinlan et al., 
1999a, 1999b; Miyazaki et al., 2006). It is conceivable that changes in amino acid 
neurotransmitters could also result in a form of neurovascular coupling - a recent 
study showed that seizure-like activity induces the expression of P-selectin and 





Figure 16: Hypothetical interaction of neuronal activity, blood vessels and                                   
macrophage responses in pain.  
 
 Increased P-selectin and ICAM-1 expression might result in recruitment of 
blood monocytes into the brain (Ling, 1979), where they could produce pro-
nociceptive substances in the CNS, such as superoxide (Cathcart, 2004), or 
peroxynitrite (Yeo et al., 2008) (Figure 16). A possible role of P-selectin in the 
development of hyperalgesia after facial carrageenan injection was therefore 
elucidated. Carrageenan-injected mice treated with P-selectin inhibitor showed 
decreased nociception, demonstrated by decreased responses to von Frey hair. These 
findings support the notion that increased P-selectin expression contributes to pro- 
rather than anti- nociception, probably through the enhancement of 
macrophage/monocyte entry into the brain. This is consistent with a previous study 
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from this laboratory which showed prolonged   macrophage/monocytes reaction in the 
caudal spinal trigeminal nucleus after facial formalin injection (Yeo et al., 2001). 
 In the periphery, ICAM-1 is up regulated in the vascular endothelium, 
simultaneously with an enhanced immigration of opioid-containing immune cells into 
inflammed paw tissue. The increase in ICAM-1 has been reported to have an anti 
nociceptive effect (Machelska et al., 2002). However, another study showed that 
hyperalgesia due to nerve growth factor (NGF) injection into the paw was dependent 
on local endothelial cell activation and increased ICAM-1 expression, and that 
antibody to ICAM-1 had an anti nociceptive effect (Foster et al., 2003). 
In conclusion, the results indicate an intimate relationship between neurons, glial 
cells, and blood vessel cells of the brain, and that the CNS vascular reaction to 
neuronal stimulus could play an important role in central sensitization of nociception, 
after peripheral inflammation, and that increased nociceptive input to the brainstem 
could attract circulating macrophages into the brain, resulting in neuroinflammation 
and pain. The present result suggests that CCL-12, ICAM-1, and P-selectin may play a 






















Knowledge of CNS gene expression changes after tissue injury or   inflammation 
and further studies which attempt to reverse facial carrageenan induced hyperalgesia 
using inhibitors to differentially expressed genes could pave the way for the 
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